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Abstract 
Background: Malaria continues to be a major health problem in low-income countries. Consequently, malaria 
control remains a public health priority in endemic countries such as Zambia. Pregnant women and children under 
5 years of age are among groups at high risk of malaria infection. Malaria infection is associated with adverse birth 
outcomes that affect the mother, foetus, and infant. Infection with HIV has been shown to increase the risk of malaria 
infection in pregnancy. The prevalence and the predictors of malaria infection among pregnant women resident in 
the Nchelenge District of northern Zambia were investigated.
Methods: Between November 2013 and April 2014, pregnant women in the catchment areas of two health centres 
were recruited during their first antenatal care visit. HIV testing was conducted as part of routine care. In addition, 
blood samples were collected from 1086 participants and tested for malaria infection using standard microscopy and 
polymerase chain reaction (PCR) techniques specific for Plasmodium falciparum. Multivariate logistic regression were 
conducted to examine the predictors of malaria infection.
Results: The prevalence of malaria identified by microscopy was 31.8 % (95 % confidence intervals [CI], 29.0–34.5; 
N = 1079) and by PCR was 57.8 % (95 % CI, 54.9–60.8; N = 1074). HIV infection was 13.2 % among women on their 
first antenatal visit; the prevalence of malaria detected by PCR among HIV-uninfected and HIV-infected women was 
56.7 % (531/936) and 65.2 % (90/138), respectively. In the final model, the risk of malaria infection was 81 % higher 
among pregnant women recruited from Nchelenge health centre compared to those attending the Kashikishi health 
centre (adjusted odds ratio = 1.81; 95 % CI, 1.38–2.37, P < 0.001), and HIV-infected women across health centres 
had a 46 % greater risk of malaria infection compared to HIV-uninfected women (adjusted odds ratio = 1.46; 95 %, 
1.00–2.13, P = 0.045).
Conclusion: High burden of malaria detected by PCR in these pregnant women suggests that past prevention 
efforts have had limited effect. To reduce this burden of malaria sustainably, there is clear need to strengthen existing 
interventions and, possibly, to change approaches so as to improve targeting of groups most affected by malaria.
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Background
Approximately 35 million pregnant women are at risk 
of malaria infection each year in sub-Saharan Africa [1]. 
Adverse consequences of malaria infection during preg-
nancy include maternal anaemia, intra-uterine growth 
retardation [2], preterm delivery [3], stillbirth [4, 5] and 
low birth weight [6]. Low birth weight is associated with 
a marked increase in neonatal death [7–10].
Meta-analysis of malaria in pregnancy (MiP) studies 
conducted in Eastern and Southern Africa between 1990 
and 2011 showed that 32.0 % (95 % confidence intervals 
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[CI], 25.9–38.0; N = 47,433) of pregnant women attend-
ing antennal care (ANC) facilities had peripheral parasi-
taemia. When the time period was restricted to studies 
conducted between 2000 and 2011, parasitaemia was 
29.5  % (95  % CI, 22.4–36.5; n  =  18,375) [11]. These 
estimates were calculated using a standard method for 
correcting errors of magnitude based on the known spec-
ificity and sensitivity of individual diagnostic methods 
[12].
Various diagnostic methods can be used in malaria 
detection. In this study microscopy and polymerase chain 
reaction (PCR) methods were employed. One advantage 
of standard microscopy is that the method requires a 
relatively short time for diagnosis when used in areas of 
high transmission and parasites are present in high con-
centrations [approximately 1000 parasites per microlitre 
(µl) of blood]. However, if parasite densities are very low, 
examination of each slide is labour-intensive [13]. More-
over, the sensitivity and specificity are greatly influenced 
by the skills and workload of microscopists [13]. In con-
trast, the use of PCR for the diagnosis of malaria is highly 
sensitive and consistent in the detection of parasites; 
PCR has the ability to measure infections where parasite 
counts are as low as 5 per µl of blood [14, 15]. However, 
some problems arise with false-negative results when 
DNA isolation is inappropriate [16, 17].
In Zambia, malaria is endemic in all 10 provinces and 
Plasmodium falciparum is responsible for approximately 
95  % of all cases [18]. Since 2006, the National Malaria 
Control Programme has conducted a Malaria Indicator 
Survey (MIS) every 2 years to measure the prevalence of 
malaria by microscopy in children under 5  years of age 
in selected sites. The prevalence of malaria parasitaemia 
decreased in Zambia from 2006 to 2010 in some regions, 
while little change was observed in others [19]. Of con-
cern is that parasitaemia declined between 2006 and 
2008 in Eastern, Northern, and Luapula Provinces, but 
was higher in the 2010 survey. There has been a 48.3 % 
decline in the national overall malaria prevalence in chil-
dren under 5 years of age between 2006 and 2012 (22.1 
versus 14.9 %), although there was only a 2.5 % reduction 
in Luapula Province (32.9 versus 32.1 %) [20].
Zambia revised its national malaria drug treatment 
policy between 2000 and 2005 to adopt artemisinin 
combination therapy (ACT) as the first-line treatment 
for uncomplicated malaria [21]. Quinine is the first-
line treatment for uncomplicated malaria in pregnancy 
in the first trimester, whereas ACT is for use in second 
and third trimesters. For complicated malaria, parenteral 
quinine is recommended in all trimesters; sulfadoxine-
pyrimethamine (SP) is used by policy for intermittent 
preventive treatment of malaria in pregnancy (IPTp) and 
also serves as a drug of choice for people who cannot 
tolerate ACT and during periods of ACT stock-outs in 
health facilities [22]. The Zambian malaria policy states 
that IPTp-SP doses are to be administered during preg-
nancy at scheduled ANC visits, spaced 1  month apart 
after 16 weeks of gestation. The 2012 MIS reported that 
84.6  % of rural and 93.0  % of urban women who had 
given birth in the five preceding years reported taking at 
least one dose of IPTp-SP [22].
Infection with HIV has been shown to impair the 
capacity of pregnant women to control peripheral and 
placental infection [23]. A review of 11 studies showed 
that HIV-infected women experience more peripheral 
and placental malaria, higher parasite densities, and 
more febrile illnesses, severe anaemia, and adverse birth 
outcomes than HIV-uninfected women [24].
The prevalence of HIV among ANC attendees in Zam-
bia is estimated to be 16.8 % in urban and 8.3 % in rural 
areas [25]. In 2010, national HIV testing among ANC 
attendees was estimated to be 94.0 % [26], and virtually 
all pregnant women are now tested for HIV. Zambia is 
listed among the 22 priority African countries with the 
highest numbers of pregnant women living with HIV who 
are in need of antiretroviral therapy for the prevention of 
mother-to-child transmission of HIV [27]. According to 
the 2013 ‘Towards Universal Access report on HIV and 
AIDS’, Zambia has made notable progress with cover-
age of maternal antiretroviral treatment (prophylaxis and 
therapy). The coverage of antiretroviral drugs for preven-
tion of mother-to-child transmission, excluding single 
dose nevarapine, was estimated to be >95  % (95  % CI, 
87—>95 %) [27].
An estimated 200,000 pregnancies in Zambia are at 
risk of malaria each year [28], however the MIS has not 
reported any estimates of malaria infection among preg-
nant women to date. Thus, this study was conducted to 
determine the prevalence of peripheral parasitaemia and 
risk factors for malaria infection from a cross-section of 
first ANC attendees in Luapula Province, an area known 
to have intense malaria transmission [29]. According to 
the Zambia Demographic and Health Survey 2013–2014, 
94.6 % of women between 15 and 49 years of age in Lua-
pula Province reported having received ANC from a 
skilled health care provider during pregnancy for their 
most recent birth in the preceding 5 years [30]. The cov-
erage of IPTp-SP reported in the MIS at provincial level 
was as follows: 89.7, 76.6, and 57.6 % of women took at 
least one dose, two or more doses, and three or more 
doses of IPTp-SP, respectively [20]. The prevalence of 
HIV among ANC attendees at the two recruitment sites 
for the study, Kashikishi and Nchelenge health centres, in 
2014 was 13.0 and 13.3 %, respectively [31]. This estimate 
combined new cases and already known HIV positive 
cases.
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Methods
Design, population and sampling procedures
This was a prospective cohort study of ANC attendees 
involving recruitment at ANC booking with follow-up to 
delivery. The study site was the catchment area for two 
health centres in Nchelenge District which is located on 
the shores of lake Mweru and has a population of 173,680 
[32]. Recruitment of participants was done at the two 
health centres between November 2013 and April 2014, 
the high malaria transmission period.
The main study was designed to estimate the preva-
lence of malaria, curable sexually transmitted and repro-
ductive tract infections and their co-infection, to explore 
determinants of poor birth outcomes in pregnancy, and 
to assess in  vivo efficacy of SP over 28  days following 
administration.
The sample size of 1086 was based on the assump-
tion that the incidence of adverse birth outcomes (low 
birth weight, stillbirth, preterm delivery or intra-uterine 
growth retardation) among women who have a malaria 
infection or a curable sexually-transmitted and reproduc-
tive tract infections infection during pregnancy would be 
at least 10 %. Thus, the sample size had 80 % power with 
95 % CIs to detect risk factors that have an odds ratio >2 
(n =  984); 10  % (n =  102) more pregnant women were 
recruited to account for expected losses to follow-up as 
observed in another MIP study in Zambia [33]. Women 
were enrolled upon providing informed written consent 
if they had not been exposed to anti-malarial and/or anti-
biotic therapy within the previous 4 weeks, were willing 
to have a member of the study team record their HIV test 
results following routine HIV screening, and had a gesta-
tional age of <32 weeks.
Data and sample collection
Data and sample collection were conducted alongside the 
provision of routine ANC activities. Routine HIV test-
ing was done using finger-prick blood with two rapid 
test kits (Determine® HIV-1/2 [Abbott] and Uni-Gold™ 
Recombigen® HIV-1/2 [Trinity Biotech]). Women were 
generally tested together with their spouses/partners. 
Individuals found to be seropositive using Determine® 
HIV-1/2 were then tested with Uni-Gold™; HIV status 
was concluded based on the result of the second test.
Trained field workers administered a questionnaire to 
participating woman in a private room. The question-
naire was used to collect information on socio-demo-
graphics, malaria prevention interventions, HIV status 
and obstetric history. Finger-prick blood was collected 
and used to prepare a thick smear from each participant 
for diagnosis of malaria by microscopy. Approximately 
160  μl of peripheral blood was placed on four circles 
of Whatman® filter paper and labelled with a unique 
identifying number for each participant and was subse-
quently used for malaria diagnosis by PCR. IPTp-SP was 
administered by direct observation to participants whose 
gestational age was >16 weeks. Women who were receiv-
ing cotrimoxazole prophylaxis were not given IPTp-SP 
due to toxicity concerns. Strips of filter paper containing 
blood spots were then air-dried and individually stored in 
envelopes pending deoxyribonucleic acid (DNA) extrac-
tion for malaria diagnosis by PCR. Thick blood films were 
stained using 10 % Giemsa solution and read by two inde-
pendent microscopists. Parasite density was determined 
by assuming 8000  white blood cells (WBCs) per µl and 
counting the number of parasites per 200 WBCs. In cases 
where fewer than nine parasites were counted against 
200  WBCs, parasites were counted against 500  WBCs. 
Two-hundred high-power fields were read before declar-
ing a slide negative. If results between two microscopists 
were discordant, a third observer read the slide to deter-
mine the diagnosis and parasite count.
DNA extraction was carried out using the Chelex 
method as described elsewhere [34]. P. falciparum was 
detected using the same nested PCR method described 
by Snounou et  al. [35], with modifications to the PCR 
parameters [36]. Briefly, all PCR reactions were carried 
out in total volumes of 25  µl using Thermo Scientific® 
Dream Taq PCR Master Mix (2X) and 0.5  µM of each 
primer and 2 µl of template; 2 µl of the primary amplicon 
was used as a template in the secondary reaction. The 
primary reaction PCR programme was as follows: initial 
denaturation at 94 °C for 3 min, followed by 30 cycles of 
denaturation at 94  °C for 1  min, annealing at 60  °C for 
2 min and extension at 72 °C for 2 min. The final exten-
sion after the 30 cycles was at 72 °C for 2 min. The sec-
ondary PCR reaction consisted of 30 cycles of reaction as 
above and the annealing temperature was at 55 °C. Nega-
tive controls were included in all extraction batches and, 
separately, a positive and a negative control were added 
to all PCR runs. The secondary amplicon was analysed by 
electrophoresis on 2 % ethidium bromide stained agarose 
gel and visualised under ultra-violet light.
Data processing and analysis
Data were double-entered in EpiData version 3.1 soft-
ware [37], cleaned, processed and analysed using Stata 
software version 13 [38]. Frequencies of all variables were 
generated to check for missing data. Variables were then 
recoded. Data on sources of income, level of education, 
and fixed and durable assets (type of roof and floor, type 
of fuel used for cooking, ownership of assets such as tel-
evision, fridges and radios) were used to create an index 
of household wealth using principal components analy-
sis [39]. Geometric means and medians were used to 
describe non-normally distributed continuous variables 
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such as parasite density and age. Characteristics of study 
participants were described using percentages and the 
Chi-squared test was used to assess differences in pro-
portions between women recruited at the two sites and 
between HIV-infected and HIV-uninfected women. 
Standard statistical tests (i.e. Mann–Whitney U test and 
t tests) were used to assess significance (P < 0.05) of dif-
ferences in the distribution of continuous variables. Para-
site densities were log-transformed before conducting 
t-tests or analyses of variance. The prevalence of malaria 
infection, determined by microscopy or by PCR, and 
their 95  % CI, were estimated. The pre-specified pri-
mary outcome was malaria measured by PCR, therefore, 
results obtained from PCR diagnosis were used to assess 
potential risk factors for malaria infection. Univari-
ate analyses of potential predictors of malaria infection 
were conducted using logistic regression, and crude odds 
ratios were estimated. Potential predictors that showed 
significance at P  <  0.1 in the univariate analysis were 
entered into a multivariable model and assessed using a 
likelihood ratio test. Factors that were found to be inde-
pendently associated with malaria infection at P  <  0.05 
were entered in a final model and adjusted odds ratios 
obtained. Independent variables in the final model were 
checked for interaction.
Ethical considerations
The study protocol was approved by the University of 
Zambia Biomedical Research Ethics Committee (ref-
erence number 004-02-13) and the London School of 
Hygiene & Tropical Medicine Observational/Interven-
tions Research Ethics Committee (reference number 
6292). Participation was voluntary and participants could 
withdraw at any time. To ensure confidentiality inter-
views were conducted privately and each participant was 
assigned a unique identifying number that was used to 
anonymize biological samples, questionnaires, and result 
record forms.
Women and/or their partners who tested HIV positive 
for the first time underwent assessment for eligibility to 
receive antiretroviral therapy and cotrimoxazole prophy-
laxis as per routine procedures. All women, except those 
currently receiving cotrimoxazole prophylaxis, were 
provided IPTp-SP according to national guidelines. In 
the rare event that a woman showed up for ANC book-
ing with symptomatic malaria, routine laboratory test-
ing was done using a rapid diagnostic test kit (SD Bioline 
Malaria Ag P.f/Pan brand; Standard Diagnostics, Inc.) 
and treatment was administered based on national policy 
guidelines. Strengthening the reporting of observational 
studies in epidemiology (STROBE) guidelines (Addi-
tional file 1) were followed in reporting this study [40].
Results
Participation and distribution
Of the 1237 women who came for ANC booking, 1095 
(89 %) were eligible for enrolment. Only 0.8 % (n = 9) of 
eligible women refused to take part in the study. A total 
of 142 women were ineligible for the following reasons: 
six were not pregnant, 116 came after 32  weeks gesta-
tion; 13 had taken anti-malarial treatment in the previ-
ous 4  weeks; five had taken anti-malarial treatment in 
the 4  weeks prior to recruitment and were more than 
32  weeks pregnant, and two had taken antibacterial 
agents in the previous 4  weeks. One woman withdrew 
consent among the 1086 participants who had been suc-
cessfully recruited.
The median age of participants was 25  years (inter-
quartile range 20–30) and the median gestational age was 
22  weeks (interquartile range 19–25.5). Nearly one-half 
of the participants, 49.2  % (n  =  534) reported owner-
ship of a bed net (treated or untreated combined). Of 531 
bed net owners, 78.3 % (n = 416) reported having slept 
under a bed net the previous night. Overall, only 38.5 % 
(n = 416) of participants slept under a bed net the pre-
vious night. Table  1 presents characteristics of women 
according to the recruitment sites. No association was 
found between site of recruitment and socio-demo-
graphic characteristics of the participants. Socio-demo-
graphic details of participants are presented in full within 
Table 1.
Malaria and HIV prevalence
The prevalence of HIV infection was 13.2  % (95  % CI, 
11.3–15.3) and the highest burden was observed in mul-
tigravidae (Table 2). The prevalence of malaria infection 
measured by microscopy was 31.8 % (95 % CI, 29.1–34.6) 
and by PCR was 57.8  % (95  % CI, 54.9–60.8). Parasite 
density ranged from 64 to 24,760 parasites per µl of blood 
with a geometric mean of 1082 (95 % CI, 962–1217) asex-
ual parasites per µl of blood. Parasite density was highest 
among primigravidae with geometric means being sig-
nificantly different across gravidae (P < 0.001). Of the 343 
malaria positive samples detected by microscopy, seven 
were negative for P. falciparum by PCR.
Of the 1074 women whose results were available for 
malaria as detected by PCR, 8.4  % (n  =  90, 95  % CI, 
6.7–10.2  %) were co-infected with HIV. Table  3 pre-
sents characteristic of HIV-infected and HIV-uninfected 
women. Infection with HIV was associated with age, gra-
vidity and bed net usage on the night before enrolment. 
Among women who tested positive for HIV, combined 
with those with known HIV-positive status, 42.7 % were 
receiving antiretroviral therapy at the time of recruit-
ment. The prevalence of malaria among HIV-infected 
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and HIV-uninfected women detected by PCR was 65.2 % 
(90/138) and 56.7 % (531/936), respectively (P = 0.059). 
In the case of microscopy, 31.3 % (294/939) of HIV-unin-
fected had parasitaemia compared to 35.0  % (49/140) 
among HIV-infected women (P  =  0.382). HIV-infected 
women had significantly higher parasite densities than 
HIV-uninfected women (P  <  0.001). Parasite density 
among HIV-infected women receiving antiretroviral 
therapy and those who were not at recruitment was not 
significantly different: 1310 (95 % CI, 693–2476, n = 15) 
and 2131 (95  % CI, 1408–3224, n  =  34), respectively 
(P = 0.189).
Table 1 Baseline characteristics of pregnant women resident in the Nchelenge district of Zambia by recruitment site
IQR interquartile range, IRS indoor residual spraying, ART antiretroviral therapy, NA not applicable
a Missing values and NA (HIV Negative) are only presented as numbers and were not included in the calculation of percentages and in the Chi-squared test for 
association
Variable All (N = 1085)
n (%) or n, median (IQR)
Kashikishi (n = 747)
n (%) or n, median (IQR)
Nchelenge (n = 338)
n (%) or n, median (IQR)
P value
Age (median) 25 (20–30) 737, 24 (20–30) 338, 25 (20–31) 0.133
Marital status 0.591
 Single 203 (18.7) 134 (17.9) 69 (20.4)
 Married 874 (80.6) 607 (81.3) 267 (80.0)
 Widowed/separated 8 (0.7) 6 (0.8) 2 (0.6)
Years of schooling 0.398
 None to 6 years 426 (39.3) 287 (38.4) 139 (41.1)
 7 years and above 659 (60.7) 460 (61.6) 199 (58.9)
Gravidity 0.657
 Primigravidae 261 (24.1) 183 (24.5) 78 (23.1)
 Secundigravidae 165 (15.2) 117 (15.6) 48 (14.2)
 Multigravidae 659 (60.7) 447 (59.8) 212 (62.7)
Bed net ownership 0.105
 No 551 (50.8) 367 (49.1) 184 (54.4)
 Yes 534 (49.2) 380 (50.9) 154 (45.6)
Bed net usage 0.349
 No 666 (61.6) 451 (60.6) 215 (63.6)
 Yes 416 (38.4) 293 (39.4) 123 (36.4)
 Missinga 3 0 3
IRS in previous 1 year 0.851
 No 808 (78.1) 563 (75.7) 245 (72.7)
 Yes 226 (21.9) 156 (21.0) 70 (20.8)
 Unknowna 51 28 23
Wealth quintile 0.089
 Lowest 217 (20.0) 135 (18.1) 82 (24.3)
 Second 221 (20.4) 151 (20.3) 70 (20.7)
 Middle 214 (19.8) 155 (20.8) 59 (17.5)
 Fourth 215 (19.9) 158 (21.20 57 (16.9)
 Highest 216 (19.9) 146 (19.6) 70 (20.7)
 Missinga 2 2 0
HIV status 0.374
 Negative 941 (86.8) 643 (86.2) 298 (88.2)
 Positive 143 (13.2) 103 (13.8) 40 (11.8)
 Missinga 1 1 0
ART among HIV-infected 0.689
 No 82 (57.3) 58 (56.3) 24 (60.0)
 Yes 61 (42.7) 45 (43.7) 16 (40.0)
 NA (HIV negative)a 941 643 298
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Figure  1 shows the prevalence of malaria infection 
among study participants each calendar month during 
the 6-month recruitment period from November 2013 
to April 2014. In the univariate analyses of recruitment 
site, age, marital status, gravidity, bed net ownership, bed 
net usage, wealth quintiles, and HIV status were associ-
ated with malaria infection at P  <  0.1. In the multivari-
ate analysis of HIV status, site of recruitment and wealth 
quintile were independently associated with malaria 
infection (Table  4). Wealth quintile was not associ-
ated with malaria infection in a model with HIV infec-
tion and site of recruitment. In the final model, the risk 
of malaria infection was higher among women recruited 
at Nchelenge health centre (adjusted odds ratio =  1.81; 
95 % CI, 1.38–2.37, P < 0.001) and
HIV-infected women across both centres (adjusted 
odds ratio = 1.46; 95 % CI 1.00–2.13, P = 0.045). There 
was no interaction between HIV status and site of 
recruitment (P = 0.751).
Discussion
This study provides a robust estimate of the prevalence 
of peripheral malaria infection among pregnant women 
of Nchelenge District. A high burden of P. falciparum 
malaria diagnosed by PCR was observed in this popula-
tion. The prevalence of malaria detected by microscopy 
was much lower than that detected by PCR, suggesting 
that a considerable proportion of this study population 
had sub-microscopic infections (smear negative but PCR 
positive). Sub-microscopic infections have been asso-
ciated with placental malaria and decreased maternal 
haemoglobin [41]. Although no association was found 
between sub-microscopic infections and adverse mater-
nal and foetal outcomes, the importance of these infec-
tions in pregnancy cannot be ignored in malaria policy 
formulation, especially when factors such as their role in 
maternal morbidity and malaria transmission are consid-
ered [41]. Moreover, pregnant women are a significant 
reservoir of gametocyte transmission and will require 
particular attention in elimination efforts [42].
Seven samples that were positive by microscopy in this 
study were found negative by PCR. Because PCR diagnos-
tic method is more precise than standard microscopy [43], 
we would expect that a malaria sample found positive by 
microscopy would also be positive by PCR. The observation 
above could be attributed to a number of factors includ-
ing malaria infection due to other Plasmodium species and 
insufficient DNA extraction. A negative PCR test result may 
be an outcome if the amount of blood collected on filter 
paper was less than 25 µl, coupled with low parasitaemia.
The prevalence of malaria infection by microscopy was 
very similar to the prevalence of parasitaemia observed 
in children less than five-years-old in 2012 (32.1  %, 
114/356) in the MIS in Luapula Province [20]. Another 
study conducted in the same area among children less 
than 10  years of age reported a similar parasite preva-
lence, 30.2 % (236/782) by microscopy [29].
Analysis of monthly-reported district-level malaria 
cases among pregnant women showed that MiP in Zam-
bia decreased between 2010 and 2013, although per-
sistent hot spots were reported in the southeast and 
northeast of the country [44].
The prevalence of malaria among 375 pregnant women 
in the study conducted in Nchelenge District between 
February and April 2013 by Siame et al. was much lower 
than what was observed in the current study, 15.0 % by 
microscopy and 22.0  % by PCR [45]. The differences in 
the prevalence of malaria in the two studies could be 
attributed to a number of factors. Firstly, in the current 
study women attending the Nchelenge and Kashikishi 
Table 2 Prevalence of Plasmodium falciparum malaria infection and parasite density at first antenatal care visit by gra-
vidity among pregnant women of Nchelenge District in Zambia
Of the expected samples from 1085 participants, 1074 were processed by PCR and 1079 by microscopy due to missing samples
95 % CI 95 % confidence interval, PCR polymerase chain reaction
a Geometric mean
b Of the 343 malaria positive samples detected by microscopy seven were found negative by PCR specific for Plasmodium falciparum detection
Infection and  
detection method
All
% (95 % CI, n/N) or
n, meana (95 % CI)
Primigravidae
% (n/N) or
n, meana (95 % CI)
Secundigravidae
% (n/N) or
n, meana (95 % CI)
Multigravidae
% (n/N) or
n, meana (95 % CI)
P value
HIV
Rapid tests
(Determine® HIV-1/2 and Uni-Gold™)
13.2 (11.3–15.3, 143/1084) 8.0 (21/261) 13.9 (23/165) 15.1 (99/658) 0.018
Malaria
PCR
57.8 (54.9–60.8, 621/1074) 68.7 (178/259) 61.8 (102/165) 52.5 (341/650) <0.001
Malaria
Microscopyb
31.8 (29.1–34.6, 343/1079) 51.0 (132/259) 37.0 (61/165) 22.9 (150/656) <0.001
Parasite density (geometric mean) 343, 1082 (962–1217) 132, 1378 (1133–1677) 61, 1164 (897–1509) 150, 848 (714–1010) <0.001
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health centres were recruited, whereas in the study by 
Siame et  al. a third health centre, Kabuta, was included 
in addition to these two. Secondly, in the study by Siame 
et  al. pregnant women who sought ANC services were 
included, regardless of visit number; in this study, only 
first ANC attendees who had not taken anti-malarial 
treatment in the previous month before recruitment were 
enrolled. Some of the participants who were included in 
the study by Siame et  al. had received IPTp-SP during 
their earlier ANC visit(s) as well as anti-malarial treat-
ment before enrolment, and it is unclear what time 
period may have elapsed between treatment and subse-
quent screening. The prevalence of malaria is likely lower 
in a group of women exposed to any IPTp-SP because 
even one dose of IPTp-SP has been shown to protect 
against maternal parasitaemia [46].
There was a difference in malaria infection and para-
site densities among HIV-infected and HIV-uninfected 
Table 3 Characteristics of HIV-uninfected and HIV-infected women of Nchelenge district in Zambia
IQR Interquartile range, IRS indoor residual spraying
a Missing values are only presented as numbers and were not included in the calculation of percentages and in the Chi-squared test for association
Variable All (N = 1084)
n (%) or n, median (IQR) or
n, mean (95 % CI)
HIV-uninfected (n = 941)
n (%) or median (IQR) or
n, mean (95 % CI)
HIV-infected (n = 143)
n (%)or n, median (IQR) or
n, mean (95 % CI)
P value
Recruitment site
 Kashikishi 746 (68.8) 643 (68.3) 103 (72.0) 0.374
 Nchelenge 338 (31.2) 298 (31.7) 40 (28.0)
Age (median) 25 (20–30) 24 (20–30) 27 (22–32) <0.001
Gravidity
 Primigravidae 261 (24.1) 240 (25.5) 21 (14.7) 0.018
 Secundigravidae 165 (15.2) 142 (15.1) 23 (16.1)
 Multigravidae 658 (60.7) 559 (59.4) 99 (69.2)
Bed net ownership
 No 550 (50.7) 472 (50.2) 78 (54.6) 0.328
 Yes 534 (49.3) 469 (49.8) 65 (45.5)
Bed net usage on previous night
 No 665 (61.5) 563 (60.0) 102 (71.8) 0.007
 Yes 416 (38.5) 376 (40.0) 40 (28.8)
Missinga 3 2 3
IRS in last 12 months
 No 665 (61.5) 563 (59.9) 102 (71.8) 0.628
 Yes 416 (38.5) 376 (40.0) 40 (28.2)
 Unknown 51 46 5
Wealth index
 Lowest 217 (20.1) 193 (20.6) 24 (16.8) 0.863
 Second 220 (20.3) 191 (20.3) 29 (20.3)
 Middle 214 (19.8) 183 (19.5) 31 (21.7)
 Fourth 215 (19.9) 185 (19.7) 30 (20.9)
 Highest 216 (20.0) 187 (19.9) 29 (20.3)
 Missinga 2 2 0
Malaria infection PCR
 Negative 453 (42.2) 405 (43.3) 48 (34.8) 0.059
 Positive 621 (57.8) 531 (56.7) 90 (65.2)
 Missinga 10 5 5
Microscopy
 Negative 736 (68.2) 645 (68.7) 91 (65.0) 0.382
 Positive 343 (31.8) 294 (31.3) 49 (35.0)
 Missinga 5 2 3
Parasite density (geometric mean) 343, 1082 (962–1217) 294, 990 (876–1120) 49, 1836 (1306–2581) <0.001
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women, a finding similar to other studies [23, 24, 47–51]. 
The proportion of malaria infection detected by micros-
copy and by PCR in this study was consistently higher in 
HIV-infected than HIV-uninfected women. HIV-infected 
women had a 46  % increased risk of malaria infection 
detected by PCR at first ANC visit (P = 0.045). However, 
the association between HIV and malaria infection was 
not statistically significant.
Previous studies have reported stronger association 
between HIV and peripheral malaria detected by micros-
copy in pregnant women. A hospital-based study in Zim-
babwe in 2000–2001 reported a high odds of malaria 
parasitaemia in HIV-infected women compared to 
HIV-uninfected women (OR 3.96; 95  % CI, 2.42–6.46) 
[50]; a study in Rwanda conducted between 1992 and 
1993 reported that the risk of parasitaemia was mod-
erately higher in HIV-infected compared to HIV-unin-
fected women (adjusted risk ratio 1.40; 95  % CI, 1.1–1.6, 
P = 0.016) [47]; a similar finding was reported from Kenya 
in a study conducted between 1996 and 1999 among HIV-
infected women in the third trimester (risk ratio 1.70; 95 % 
CI, 1.52–1.90) and at delivery (risk ratio 1.56; 95  % CI, 
1.34–1.81) [51]. The prevalence of malaria parasitaemia 
among HIV-infected women at first ANC visit was higher 
than among HIV-uninfected women in a study in Malawi 
conducted between 1987 and 1990 (56.6 versus 43.6  %, 
P < 0.001) [49].
The use of antiretroviral therapy was not stated in all 
the studies above and, considering the years in which 
these studies were conducted, it can be assumed that cov-
erage of antiretroviral therapy among pregnant women 
was very low if not non-existent. In the current study, 
however, the coverage of antiretroviral therapy at first 
ANC visit was 42.7  % among all HIV-positive women, 
newly-tested and known HIV-positive cases. Some of 
the women who were screened in the current study were 
receiving co-trimoxazole prophylaxis although coverage 
data of cotrimoxazole at recruitment was not collected. 
However, data from delivery showed that 37  % of HIV-
infected study participants had received cotrimoxa-
zole prophylaxis during pregnancy. Thus, the relatively 
a weaker association between HIV-infected status and 
malaria parasitaemia observed in the current study com-
pared to the previously reported studies could be due to 
the fact that some of the HIV-infected women were on 
ARV and/or cotrimoxazole prophylaxis.
There was no difference in the geometric mean of 
parasite density in HIV-infected women on antiretrovi-
ral therapy and women who were not on treatment. This 
may be attributable to newer HIV infections. Women 
who were not already on antiretroviral therapy may not 
have progressed to a state of highly compromised immu-
nity since some of them tested positive for the first time 
at their ANC booking. Furthermore, eligibility to receive 
antiretroviral drugs in this community was linked to CD4 
count. Therefore, if women known to be HIV-positive 
were not on therapy, it was likely that their CD4 count 
was above 500 cells per cubic millimetre of blood.
PCR: Polymerase chain reacon 
Mm: Millimetres 
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The fact that bed net usage was much lower in HIV-
infected women than in HIV-uninfected women, despite 
there being no significant difference in bed net ownership 
in the two groups, is surprising because one might expect 
the opposite. It is unclear if low bed net usage confers 
an additional risk of malaria infection in HIV-infected 
women in this study group as would be expected consid-
ering that no association was found between bed net use 
and malaria infection in this study. The significant differ-
ence in use of bed nets suggests that there could be dif-
ferences in disease prevention behaviours between the 
two groups.
Table 4 Predictors of malaria infection diagnosed by PCR among pregnant women of Nchelenge district in Zambia
Totals of individual variables less than 1074 (available results for malaria diagnosed by polymerase chain reaction) are indicated in the first column. These were due to 
missing values in individual variables
IRS Indoor residual spraying, HIV human immunodeficiency virus
a The group included women who had been married before (divorced/separated or widowed)
b Total number was 1025 due to the exclusion of the ‘unknown’ response. Some women did not know if IRS had been applied to their houses due to occupying them 
in less than 12 months
* When wealth quintile was put in the model with HIV and site of recruitment it was not significantly associated with malaria infection at P < 0.05 and was therefore 
excluded from the final model. There was no interaction between HIV infection and site of recruitment in the final model (P = 0.751)
Potential risk  
factor category
Number in each 
category
% Unadjusted OR P value Adjusted OR for  
multivariate analysis
P value Adjusted OR 
for final model
P value
Total 1074 100 1074 1068 <0.001 1072 <0.001
Recruitment site <0.001 <0.001 <0.001
 Kashikishi 737 68.6 1.00 1.00 1.00
 Nchelenge 337 31.4 1.80 (1.37–2.35) 1.89 (1.43–2.50) 1.81 (1.38–2.37)
Age group <0.001 0.145
 ≤20 295 27.5 1.00 1.00
 21–25 304 28.3 0.51 (0.37–0.72) 0.63 (0.41–0.98)
 26–30 244 22.7 0.51 (0.36–0.73) 0.67 (0.41–1.20)
 ≥30 231 21.5 0.45 (0.32–0.64) 0.57 (0.34 –0.95)
Marital status 0.043 0.412
 Single 201 18.7 1.00 1.00
 Marrieda 873 81.3 0.72 (0.52–0.99) 1.18 (0.78–1.80)
Gravidity <0.001 <0.069
 Primigravidae 259 24.1 1.00 1.00
 Secundigravidae 165 15.4 0.74 (0.48–1.11) 0.80 (0.48–1.33)
 Multigravidae 650 60.5 0.50 (0.37–0.68) 0.58 (0.35–0.95)
Bed-net ownership 0.015 0.640
 No 547 50.9 1.00 1.00
 Yes 527 49.1 0.74 (0.58–0.94) 1.13 (0.72–1.73)
Bed-net usage (1071) 0.006 0.213
 No 659 61.5 1.00 1.00
 Yes 412 38.5 0.75 (0.48–0.91) 0.74 (0.48–1.18)
IRS in past 12 months 
(1025)b
0.257
 No 800 78.1 1.00
 Yes 225 21.9 1.19 (0.88–1.61)
Wealth quintiles (1072) 0.072 0.027*
 Lowest 216 20.1 1.00 1.00
 Second 219 20.4 0.80 (0.54–1.17) 0.73 (0.50–1.09)
 Middle 209 19.5 0.91 (0.61–1.34) 0.76 (0.51–1.15)
 Fourth 214 20.0 1.08 (0.73–1.60) 0.90 (0.59–1.38)
 Highest 214 20.0 0.64 (0.44–0.95) 0.52 (0.35–0.80)
HIV infection 0.057 0.025 0.045
 Negative 936 87.1 1.00 1.00 1.00
 Positive 138 12.9 1.30 (0.91–1.88) 1.62 (1.09–2.39) 1.46 (1.00–2.13)
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In the univariate analysis, the risk of infection was 
strongly associated with gravidity and age, but this was 
not observed in the multivariate analysis. Studies have 
shown that in malaria-endemic areas, the prevalence 
of malaria, both clinical and asymptomatic, is highest 
in young women and primigravidae and paucigravidae 
(primigravidae and secundigravidae combined) [2, 52, 
53]. This is due to acquisition of semi-immunity that is 
gravidity-dependent such that malaria infection tends to 
be less prevalent and less severe among multigravidae [2, 
6, 52]. However, HIV infection has been shown to impair 
the ability of multigravidae to manage malaria infection 
[23, 51]. The fact that HIV prevalence was highest among 
multigravidae in this study population is a plausible expla-
nation for the fact that there was no association between 
parity and malaria infection in multivariate analysis.
The low coverage of IRS and bed net use in an area of 
intense transmission may partially explain the high prev-
alence of malaria infection. Despite the progress that has 
been made in scaling-up malaria control interventions, 
a high burden of malaria still remains in Nchelenge Dis-
trict [19, 54]. Several reasons may underlie this observa-
tion including population movements from high endemic 
areas (internally and across borders), increasing parasite 
resistance to insecticides [29, 54], as well as homes hav-
ing been built close to water sources that serve as breed-
ing grounds for Anopheles mosquitoes.
The risk of malaria infection was higher among women 
at Nchelenge health centre compared to Kashikishi 
health centre. Since there was no difference in socio-
demographic characteristics and HIV infection at the two 
sites, this difference in the risk of malaria infection may 
be attributable to the intensity of malaria transmission 
within the catchment areas of Kashikishi and Nchelenge 
health centres. Apart from providing health services to 
the people living close to the Lake Mweru, Nchelenge 
health centre also provides health services to people in 
villages that are close to a rubber plantation, the Kenani 
River, and other in-land water bodies in the Robert 
Mutepuka village area which provide more breeding sites 
for mosquitoes.
Malaria transmission intensity is known to decrease 
during the winter months, April to August, in Nchelenge 
District [18]. Thus, the estimated prevalence of MiP from 
this study conducted during the hot rainy season from 
November to April is probably higher than the prevalence 
at other times of the year. Zambia has different malaria 
transmission zones ranging from very low, to low-mod-
erate and moderate-high [55]. Thus, the prevalence of 
malaria estimated in this study can only be cautiously 
extended to areas with similar transmission patterns.
The prevalence of P. falciparum malaria detected by 
PCR in pregnant women of Nchelenge District is high. 
HIV infection increased the risk of malaria infection, 
although our sample size was not large enough to con-
clude this risk was statistically significant. Robust vector 
control, the provision of IPTp-SP, and community educa-
tion on the importance of using the available interven-
tions to prevent and to treat MiP are vital to reducing 
the malaria burden in pregnancy. The high prevalence 
of malaria infection that we observed in this population 
suggests that past prevention efforts have had limited 
impact in pregnant women.
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